{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T10:31:50Z","timestamp":1773052310065,"version":"3.50.1"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T00:00:00Z","timestamp":1597276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000833","name":"Rosetrees Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000833","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.01844","type":"journal-article","created":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T05:20:57Z","timestamp":1597296057000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":67,"title":["Immunomodulatory Drugs in the Management of SARS-CoV-2"],"prefix":"10.3389","volume":"11","author":[{"given":"Daniel R.","family":"Burrage","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soraya","family":"Koushesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nidhi","family":"Sofat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,8,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1007\/s10067-020-05073-9","article-title":"Rheumatologists' perspectives on coronavirus (COVID-19) and potential therapeutic targets","volume":"39","author":"Misra","year":"2020","journal-title":"Clin Rheumatol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"m1432","DOI":"10.1136\/bmj.m1432","article-title":"Chloroquine and hydroxychloroquine in covid-19","volume":"369","author":"Ferner","year":"2020","journal-title":"BMJ."},{"key":"B3","unstructured":""},{"key":"B4","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1007\/s00134-020-05991-x","article-title":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China","volume":"46","author":"Ruan","year":"2020","journal-title":"Intensive Care Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0140-67362030628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet."},{"key":"B6","volume-title":"EPAR RoActemra.","year":"2019"},{"key":"B7","doi-asserted-by":"publisher","first-page":"10970","DOI":"10.1073\/pnas.2005615117","article-title":"Effective treatment of severe COVID-19 patients with tocilizumab","volume":"117","author":"Xu","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"B8","unstructured":""},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1101\/2020.04.08.20057794","article-title":"Factors associated with hospitalization and critical illness among 4,103 patients with COVID-19 disease in New York City","author":"Petrilli","year":"2020","journal-title":"MedRxiv [Preprint]"},{"key":"B10","doi-asserted-by":"publisher","first-page":"152","DOI":"10.3389\/fpubh.2020.00152","article-title":"Gender differences in patients with COVID-19: focus on severity and mortality","volume":"8","author":"Jin","year":"2020","journal-title":"Front Public Health"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1016\/S0140-6736(20)30922-3","article-title":"Ethnicity and COVID-19: an urgent public health research priority","volume":"395","author":"Pareek","year":"2020","journal-title":"Lancet"},{"key":"B12","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1093\/cid\/ciaa415","article-title":"Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission","volume":"71","author":"Lighter","year":"2020","journal-title":"Clin Infect Dis"},{"key":"B13","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.dsx.2020.04.018","article-title":"Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia\u2013a systematic review, meta-analysis, and meta-regression","volume":"14","author":"Huang","year":"2020","journal-title":"Diabetes Metab Syndr"},{"key":"B14","unstructured":""},{"key":"B15","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/nrd3800","article-title":"Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases","volume":"11","author":"Dinarello","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"B16","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1093\/rheumatology\/kex427","article-title":"Adult-onset tumour necrosis factor-receptor associated periodic syndrome presenting as transfusion-dependent refractory haemophagocytosis","volume":"57","author":"Youngstein","year":"2018","journal-title":"Rheumatology."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.23812\/CONTI-E","article-title":"Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by coronavirus-19 (COVID-19 or SARS-CoV-2): anti-inflammatory strategies","volume":"34","author":"Conti","year":"2020","journal-title":"J Biol Regul Homeost Agents."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2566","DOI":"10.1002\/1521-414120010931:92566::AID-IMMU25663.0.CO;2-L","article-title":"Inhibition of tumor necrosis factor reduces the severity of virus-specific lung immunopathology","volume":"31","author":"Hussell","year":"2001","journal-title":"Eur J Immunol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.rdc.2015.08.002","article-title":"Corticosteroids \u2013 Mechanisms of action in health and disease","volume":"42","author":"Ramamoorthy","year":"2016","journal-title":"Rheum Dis Clin North Am."},{"key":"B20","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jsbmb.2010.02.018","article-title":"Mechanisms and resistance in glucocorticoid control of inflammation","volume":"120","author":"Barnes","year":"2010","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.3332\/ecancer.2020.1023","volume":"14","year":"2020","journal-title":"Ecancermedicalscience"},{"key":"B22","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1093\/jac\/dkn243","article-title":"The management of coronavirus infections with particular reference to SARS","volume":"62","author":"Wong","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"B23","unstructured":""},{"key":"B24","unstructured":""},{"key":"B25","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1365-2125.1989.tb03439.x","article-title":"Bioavailability of hydroxychloroquine tablets in healthy volunteers","volume":"27","author":"Tett","year":"1989","journal-title":"Br J Clin Pharmacol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"6027","DOI":"10.1096\/fj.202000919","article-title":"Rethinking the role of hydroxychloroquine in the treatment of COVID-19","volume":"34","author":"Meyerowitz","year":"2020","journal-title":"FASEB J."},{"key":"B27","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1101\/2020.04.08.20054551","article-title":"Safety of hydroxychloroquine, alone and in combination with azithromycin, in light of rapid widespread use for Covid-19: a multinational, network cohort and self-controlled case series study","author":"Lane","year":"2020","journal-title":"medRxiv."},{"key":"B29","unstructured":""},{"key":"B30","doi-asserted-by":"publisher","first-page":"i17","DOI":"10.1093\/rheumatology\/key225","article-title":"Clinical efficacy of launched JAK inhibitors in rheumatoid arthritis","volume":"58","author":"Taylor","year":"2019","journal-title":"Rheumatology"},{"key":"B31","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1136\/annrheumdis-2019-216653","article-title":"Safety of synthetic and biological DMARDs: a systematic literature review informing the 2019 update of the EULAR recommendations for the management of rheumatoid arthritis","volume":"79","author":"Sepriano","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30270-X","article-title":"Baricitinib for COVID-19: a suitable treatment","author":"Richardson","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2020.04.017","article-title":"Bariticinib therpay in COVID-19: a pilot study on safety and clinical impact","author":"Cantini","year":"2020","journal-title":"J Infect"},{"key":"B34","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1056\/NEJMc2009567","article-title":"Covid-19 in immune-mediated inflammatory diseases \u2013 Case series from New York","volume":"383","author":"Haberman","year":"2020","journal-title":"N Engl J Med"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1177\/0961203315593169","article-title":"Colchicine: a simple and effective treatment for pericarditis in systemic lupus erythematosus? A report of 10 cases","volume":"24","author":"Morel","year":"2015","journal-title":"Lupus"},{"key":"B36","doi-asserted-by":"publisher","first-page":"566","DOI":"10.2217\/14796678.4.6.599","article-title":"Colchicine for the treatment of pericarditis","volume":"4","author":"Imazio","year":"2008","journal-title":"Future Cardiol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1093\/cvr\/cvaa106","article-title":"COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis and treatment options","volume":"116","author":"Guzik","year":"2020","journal-title":"Cardiovas. Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e02325","DOI":"10.1128\/mBio.02325-17","article-title":"Role of severe acute respiratory syndrome coronavirus viroporins E, 3a, and 8a in replication and pathogenesis","volume":"9","author":"Casta\u00f1o-Rodriguez","year":"2018","journal-title":"MBio"},{"key":"B39","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/ni.2550","article-title":"Microtubule-driven spatial arrangement of mitochondria promotes activation of the NLRP3 inflammasome","volume":"14","author":"Misawa","year":"2013","journal-title":"Nat Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01844\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T05:21:03Z","timestamp":1597296063000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01844\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,13]]},"references-count":39,"alternative-id":["10.3389\/fimmu.2020.01844"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.01844","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,13]]},"article-number":"1844"}}